Investigating the role of specific enzymes in bladder cancer development
Targeting APOBEC3-induced squamous differentiation in bladder cancer
['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-11133494
This study is looking at how certain enzymes might play a role in bladder cancer, and it's using a special mouse model to find out how these enzymes cause changes that can lead to cancer, with the hope of discovering new treatment options for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-11133494 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how enzymes from the APOBEC3 family contribute to the development and progression of bladder cancer, particularly urothelial carcinomas. By using a novel mouse model, researchers will explore the mechanisms by which these enzymes induce mutations that lead to cancer. The study aims to identify potential therapeutic targets by examining the effects of APOBEC3 on tumor formation and differentiation in bladder cancer. Patients may benefit from insights gained that could lead to new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with bladder cancer, particularly those with urothelial carcinoma.
Not a fit: Patients with non-cancerous bladder conditions or those with other types of cancer may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches for treating bladder cancer.
How similar studies have performed: Previous research has shown that targeting mutational processes in cancer can lead to significant advancements in treatment, suggesting this approach may also yield promising results.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KIM, WILLIAM Y. — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: KIM, WILLIAM Y.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.